In immunodeficient NPG mice preconditioned with HCT116 tumor cells, intravenously injected CD45 + hESC-derived eosinophils infiltrated the tumor, restricted tumor growth, and prolonged the median survival time of the mice in both inoculated tumors and established tumors. This evidence concerns the gene PTPRC and neoplasm.